// App-Quantinova.ai

3383 : ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates

Researchers

Presenter

  • Pier Mannuccio Mannucci

Principal Investigators

  • Carla Valsecchi

  • Silvia Pontiggia

  • Jonathan Bernstein

  • Stefano Guazzini

  • Anastassios Retzios

Medical Centers

  • IRCCS C- Granda Maggiore Hospital Foundation, Milano, Italy

  • U.O.S. Dipartimentale per la Diagnosi e la Terapia delle Coagulopatie, A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione I.R.C.C.S. C- Granda - Ospedale Maggiore Policlinico, Universita degli Studi di Milano and Luigi Villa Foundation, Milan, Italy,

  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy

  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy

Locations

  • Italy

Companies

  • Kedrion Biopharma In

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombotic thrombocytopenic purpura

  • Venous thrombosis

Biomarkers

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • FVIII

  • Alphanate

  • Koate-DVI human

  • Humate-P

  • Wilate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved